Company: MIRA
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001183
Chunk: 1152

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9C
Chunk 1152
---
 an insider trading policy filed hereto as Exhibit 19.1 and is incorporated herein by this reference.

Corporate
Governance Guidelines

Our
board of directors has adopted corporate governance guidelines, a copy of which is available on our website.

Director
Compensation

We
did not provide any cash compensation to any of our directors during the year ended December 31, 2024 in their capacity as directors.
However, on April 25, 2024, Matthew Del Giudice, Edward MacPherson, and Denil Shekhat were granted an option to purchase up to 50,000
shares of our common stock under the 2022 Omnibus Plan for joining the board. Additionally, on December 6, 2024, each non-employee director
was granted an additional option to purchase up to 25,000 shares of our common stock under the 2022 Omnibus Plan. Each such option vested
in terms ranging from immediate vesting to one year following the grant. Each grant has a 10-year term.

Item
11. Executive Compensation

This
section discusses the material components of the executive compensation program for the following persons: (i) all persons serving as
our principal executive officers during 2024 and (ii) the most highly compensated of our other executive officers who received compensation
during 2024 of at least $100,000 and who were executive officers on December 31, 2024. We refer to these persons as our “named
executive officers” elsewhere in this Report. Our “named executive officers” and their positions are as follows:

    ●
    Erez
    Aminov, Chief Executive Officer and Chairman;

    ●
    Michelle
    Yanez, MBA, Chief Financial Officer, Secretary and Treasurer. 

71

Summary
Compensation Table

The
following table shows the compensation paid by us during the 2024 and 2023 fiscal years to our named executive officers.

    Name
    and principal position 
    Year  
    Salary
    ($)  
    Bonus
    ($)  
    Stock
    Awards ($)  
    Option
    Awards ($) (6)  
    Non-Equity
    Incentive Plan Compensation ($)  
    Nonqualified
                                            Deferred Compensation Earnings ($)  
    All
    Other Compensation ($)  
    Total ($) 
  
    Erez
    Aminov, 
    2024  
     259,999